Cvd Risk Assessment: From Cholesterol Screening To Deprescribing Statins

CVD risk assessment: from cholesterol screening to deprescribing statins

Webinar | Lipids in the limelight: clinical update on screening and management | Heart Foundation

Heart Foundation

Assessment and Mitigation of Lipid-Associated CVD Risk in Young Adults

Emory Cardiology

Risk Assessment in Dyslipidemia For Specialists: An Expert Walkthrough

Dyslipidemia: Adherence, Targets, Non-Statin Drugs: 2016 Guidelines

Canadian Cardiovascular Society

David Sullivan - Opportunities to simplify clinical lipid assessment

Statin Therapy for High-Risk Groups Summary Video

South Peace Polypharmacy Project LS 4: Statins in Older Adults

Optimizing Lipid Risk Factors: Focus on Residual Risk, Dr. David Vorchheimer

MonteHeart Lectures

ESC Guidelines, Target Population of CVD Screening (English Version)

CardioMinds, Dr. Sherif Altoukhy

Management of Hyperlipidemia in Statin-Treated or Statin-Intolerant High-Risk ASCVD Patients

Dr. Bret Scher - 'Assessing Cardiovascular Risk With LCHF'

Low Carb Down Under

A New Way to Assess Cardiovascular Disease Risk

Tracking Cholesterol and Cardiovascular Risk

National Jewish Health

Taking a holistic approach to lipid disorders - Sue Kemsley

Health Innovation North West Coast

Statin Therapy: Risk for Future CV Events

Elevated Triglycerides, CV Risk & Costs in Statin-treated Patients

Mayo Proceedings

Dyslipidemia: Risk Assessment - 2016 Guidelines

Canadian Cardiovascular Society

How to Gauge 10-Year Atherosclerotic CVD Risk for Patients

Pharmacy Times TV

Statin Therapy For High Cardiovascular Risk | Statins & ASCVD |